Table 3.
Reliever inhaler only (n=415) | Controller inhaler only (n=74) | Reliever and controller inhalers only (n=246) | Oral pills plus inhaler(s) (n=538) | |
---|---|---|---|---|
Asthma control and symptoms (past 7 days) | ||||
GINA-defined control level, n (%) | ||||
Controlled | 60 (14.5) | 12 (16.2) | 24 (9.8) | 43 (8.0) |
Partially controlled | 148 (35.7) | 23 (31.1) | 79 (32.1) | 164 (30.5) |
Uncontrolled | 207 (49.9) | 39 (52.7) | 143 (58.1) | 331 (61.5) |
Daytime asthma symptoms, n (%) | ||||
None | 79 (19.0) | 15 (20.3) | 33 (13.4) | 52 (9.7) |
≥1 day | 202 (48.7) | 33 (44.6) | 106 (43.1) | 252 (46.8) |
≥3 days | 134 (32.3) | 26 (35.1) | 107 (43.5) | 234 (43.5) |
Activity limitation due to asthma, n (%) | ||||
None | 143 (34.5) | 27 (36.5) | 68 (27.6) | 140 (26.0) |
2 days or less | 177 (42.7) | 26 (35.1) | 118 (48.0) | 250 (46.5) |
>2 days | 95 (22.9) | 21 (28.4) | 60 (24.4) | 148 (27.5) |
Night waking, n (%) | ||||
None | 118 (28.4) | 19 (25.7) | 60 (24.4) | 93 (17.3) |
≥1 day | 297 (71.6) | 55 (74.3) | 186 (75.6) | 445 (82.7) |
Reliever needed for symptoms, n (%) | ||||
Not used | 85 (20.5) | 26 (35.1) | 41 (16.7) | 78 (14.5) |
Two times or less | 176 (42.4) | 17 (23.0) | 82 (33.3) | 217 (40.3) |
>2 times | 154 (37.1) | 31 (41.9) | 123 (50.0) | 243 (45.2) |
Acute exacerbations (past 12 months) | ||||
Oral steroid use for worsening asthma, n (%) | ||||
None | 142 (34.2) | 20 (27.0) | 78 (31.7) | 56 (10.4) |
≥1 course | 273 (65.8) | 54 (73.0) | 168 (68.3) | 482 (89.6) |
Antibiotic use for an asthma-associated condition, n (%) | ||||
Not used | 105 (25.3) | 25 (33.8) | 59 (24.0) | 59 (11.0) |
≥1 course | 310 (74.7) | 49 (66.2) | 187 (76.0) | 479 (89.0) |
Emergency department visit due to asthma, n (%) | ||||
None | 274 (66.0) | 52 (70.3) | 136 (55.3) | 270 (50.2) |
≥1 visit | 141 (34.0) | 22 (29.7) | 110 (44.7) | 268 (49.8) |
Overnight hospitalization due to asthma, n (%) | ||||
None | 283 (68.2) | 55 (74.3) | 159 (64.6) | 279 (51.9) |
≥1 stay | 132 (31.8) | 19 (25.7) | 87 (35.4) | 259 (48.1) |
Abbreviation: GINA, Global Initiative for Asthma.